Urinary aflatoxin biomarkers and risk of hepatocellular carcinomaR K Ross, John D. Groopman, M C Yu et al.|The Lancet|1992Cited by 731
Aflatoxin: A 50-Year Odyssey of Mechanistic and Translational ToxicologyThomas W. Kensler, John D. Groopman, Bill D. Roebuck et al.|Toxicological Sciences|2010Cited by 677
A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China.Geng-Sun Qian, John D. Groopman, M C Yu et al.|PubMed|1994Cited by 677
Molecular dosimetry of urinary aflatoxin-DNA adducts in people living in Guangxi Autonomous Region, People's Republic of China.John D. Groopman, Gerald N. Wogan, Jinfeng Zhu et al.|PubMed|1992Cited by 207
Serum albumin adducts in the molecular epidemiology of aflatoxin carcinogenesis: correlation with aflatoxin B<sub>1</sub> intake and urinary excretion of aflatoxin M<sub>1</sub>Liang‐Shang Gan, Steven R. Tannenbaum, Jun-shi Chen et al.|Carcinogenesis|1988Cited by 189